Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Insulin for Prevention of Postoperative Delirium in Older Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

NCT07720479 is registered in ClinicalTrials.gov with Weidong Mi as lead sponsor.

NCT NCT07720479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Insulin for Prevention of Postoperative Delirium in Older Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
Lead sponsor
Weidong Mi
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
February 1, 2028
Enrollment
210 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative delirium (pod)